2-(3,4-Dimethoxyphenyl)benzothiazole - CAS 6638-45-5
Catalog: |
BB033015 |
Product Name: |
2-(3,4-Dimethoxyphenyl)benzothiazole |
CAS: |
6638-45-5 |
Synonyms: |
2-(3,4-dimethoxyphenyl)-1,3-benzothiazole; 2-(3,4-dimethoxyphenyl)-1,3-benzothiazole |
IUPAC Name: | 2-(3,4-dimethoxyphenyl)-1,3-benzothiazole |
Description: | 2-(3,4-Dimethoxyphenyl)benzothiazole (CAS# 6638-45-5 ) is a useful research chemical. |
Molecular Weight: | 271.33 |
Molecular Formula: | C15H13NO2S |
Canonical SMILES: | COC1=C(C=C(C=C1)C2=NC3=CC=CC=C3S2)OC |
InChI: | InChI=1S/C15H13NO2S/c1-17-12-8-7-10(9-13(12)18-2)15-16-11-5-3-4-6-14(11)19-15/h3-9H,1-2H3 |
InChI Key: | JMSHSEQKUVZWNO-UHFFFAOYSA-N |
Boiling Point: | 419.7 °C at 760 mmHg |
Density: | 1.235 g/cm3 |
LogP: | 3.98050 |
Publication Number | Title | Priority Date |
CN-105884714-A | Method for realizing green synthesis of 2-substituted benzothiazole derivatives | 20160503 |
CN-105884714-B | A kind of green syt 2- replaces the method for benzo thiazole derivative | 20160503 |
EP-3296294-A1 | Compound for treating or preventing breast cancer | 20150509 |
US-10005744-B2 | Compounds for the treatment or prevention of breast cancer | 20150509 |
US-2018134673-A1 | Compounds for the treatment or prevention of breast cancer | 20150509 |
PMID | Publication Date | Title | Journal |
21684753 | 20110715 | Synthesis of novel inhibitors of β-glucuronidase based on benzothiazole skeleton and study of their binding affinity by molecular docking | Bioorganic & medicinal chemistry |
21397499 | 20110415 | Synthesis and biological activity of hydroxy substituted phenyl-benzo[d]thiazole analogues for antityrosinase activity in B16 cells | Bioorganic & medicinal chemistry letters |
19215089 | 20090312 | A basis for reduced chemical library inhibition of firefly luciferase obtained from directed evolution | Journal of medicinal chemistry |
16392802 | 20060112 | Antitumor benzothiazoles. 26.(1) 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective inhibitory activity against lung, colon, and breast cancer cell lines | Journal of medicinal chemistry |
Complexity: | 302 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 271.06669983 |
Formal Charge: | 0 |
Heavy Atom Count: | 19 |
Hydrogen Bond Acceptor Count: | 4 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 271.06669983 |
Rotatable Bond Count: | 3 |
Topological Polar Surface Area: | 59.6 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 4.2 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Benzoxazole/Benzothiazole
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS